ENTRY       D00640                      Drug
NAME        Propafenone hydrochloride (JP18/USP);
            Rythmol (TN)
PRODUCT     RYTHMOL (GlaxoSmithKline LLC)
  GENERIC   PROPAFENONE HCL (Actavis Pharma)
            PROPAFENONE HYDROCHLORIDE (ANI Pharmaceuticals)
            PROPAFENONE HYDROCHLORIDE (Actavis Pharma)
            PROPAFENONE HYDROCHLORIDE (American Health Packaging)
            PROPAFENONE HYDROCHLORIDE (American Health Packaging)
            PROPAFENONE HYDROCHLORIDE (American Health Packaging)
            PROPAFENONE HYDROCHLORIDE (Aurobindo Pharma Limited)
            PROPAFENONE HYDROCHLORIDE (Aurobindo Pharma Limited)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Bryant Ranch Prepack)
            PROPAFENONE HYDROCHLORIDE (Cadila Healthcare Limited)
            PROPAFENONE HYDROCHLORIDE (Glenmark Pharmaceuticals)
            PROPAFENONE HYDROCHLORIDE (Golden State Medical Supply)
            PROPAFENONE HYDROCHLORIDE (Golden State Medical Supply)
            PROPAFENONE HYDROCHLORIDE (Golden State Medical Supply)
            PROPAFENONE HYDROCHLORIDE (Northstar Rx LLC)
            PROPAFENONE HYDROCHLORIDE (Par Pharmaceutical)
            PROPAFENONE HYDROCHLORIDE (Par Pharmaceutical)
            PROPAFENONE HYDROCHLORIDE (Proficient Rx LP)
            PROPAFENONE HYDROCHLORIDE (Rising Pharma Holdings)
            PROPAFENONE HYDROCHLORIDE (Strides Pharma Science Limited)
            PROPAFENONE HYDROCHLORIDE (Strides Pharma Science Limited)
            PROPAFENONE HYDROCHLORIDE (Sun Pharmaceutical Industries)
            PROPAFENONE HYDROCHLORIDE (TWi Pharmaceuticals)
            PROPAFENONE HYDROCHLORIDE (Upsher-Smith Laboratories)
            PROPAFENONE HYDROCHLORIDE (Vitruvias Therapeutics)
            PROPAFENONE HYDROCHLORIDE (Zydus Pharmaceuticals (USA))
FORMULA     C21H27NO3. HCl
EXACT_MASS  377.1758
MOL_WEIGHT  377.9049
CLASS       Cardiovascular agent
             DG01653  Antiarrhythmics
              DG01652  Class I antiarrhythmic agent
               DG01650  Class Ic antiarrhythmic agent
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2129
            ATC code: C01BC03
            Chemical structure group: DG00200
            Product (DG00200): D00640<JP/US>
EFFICACY    Antiarrhythmic, Sodium channel blocker
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes
            hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576], CYP1A2 [HSA:1544]
INTERACTION  
STR_MAP     map07037  Antiarrhythmic drugs
            map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BC Antiarrhythmics, class Ic
                 C01BC03 Propafenone
                  D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Antiarrhythmics
               Vaughn Williams-Class I
                Propafenone
                 D00640  Propafenone hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               212  Antiarrhythmic agents
                2129  Others
                 D00640  Propafenone hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01650  Class Ic antiarrhythmic agent
                 DG00200  Propafenone
                  D00640  Propafenone hydrochloride
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00200  Propafenone
                D00640  Propafenone hydrochloride
              DG01644  CYP2D6 substrate
               DG00200  Propafenone
                D00640  Propafenone hydrochloride
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00200  Propafenone
                 D00640  Propafenone hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               D00640  Propafenone hydrochloride
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN2A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN3A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN4A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN5A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN8A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN9A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN10A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
                SCN11A
                 D00640  Propafenone hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00640  Propafenone hydrochloride
              D00640  Propafenone hydrochloride tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00640
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D00640
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01650  Class Ic antiarrhythmic agent
                 DG00200  Propafenone
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG00200  Propafenone
              DG01644  CYP2D6 substrate
               DG00200  Propafenone
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00200  Propafenone
DBLINKS     CAS: 34183-22-7
            PubChem: 7847706
            ChEBI: 8466
            LigandBox: D00640
            NIKKAJI: J252.813D
ATOM        26
            1   C8y C    27.3415  -18.7772
            2   C8y C    27.3474  -20.1862
            3   O2a O    26.1247  -18.0844
            4   C8x C    28.5641  -18.0785
            5   C5a C    26.1363  -20.8906
            6   C8x C    28.5641  -20.8849
            7   C1b C    26.1363  -16.6871
            8   C8x C    29.7753  -18.7772
            9   C1b C    24.9311  -20.1919
            10  O5a O    26.1422  -22.2880
            11  C8x C    29.7693  -20.1803
            12  C1c C    24.9311  -15.9825
            13  C1b C    23.7259  -20.8965
            14  C1b C    23.7259  -16.6928
            15  O1a O    24.9253  -14.5851
            16  C8y C    22.5090  -20.2036
            17  N1b N    22.5149  -15.9941
            18  C8x C    22.5090  -18.8005
            19  C8x C    21.3097  -20.9082
            20  C1b C    21.3097  -16.6987
            21  C8x C    21.2921  -18.1135
            22  C8x C    20.0869  -20.2212
            23  C1b C    20.0928  -16.0000
            24  C8x C    20.0754  -18.8121
            25  C1a C    18.8819  -16.7045
            26  X   Cl   31.8596  -18.4395
BOND        26
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     4   8 1
            8     5   9 1
            9     5  10 2
            10    6  11 1
            11    7  12 1
            12    9  13 1
            13   12  14 1
            14   12  15 1
            15   13  16 1
            16   14  17 1
            17   16  18 2
            18   16  19 1
            19   17  20 1
            20   18  21 1
            21   19  22 2
            22   20  23 1
            23   21  24 2
            24   23  25 1
            25    8  11 2
            26   22  24 1
///
